These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 7033372)

  • 1. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
    Lambris JD; Ross GD
    J Immunol; 1982 Jan; 128(1):186-9. PubMed ID: 7033372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of neutrophil expression of C3b receptors (CR1) by soluble monomeric human C3b.
    Porteu F; Mir A; Halbwachs-Mecarelli L
    Eur J Immunol; 1987 May; 17(5):629-35. PubMed ID: 2953614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.
    Molina H; Kinoshita T; Webster CB; Holers VM
    J Immunol; 1994 Jul; 153(2):789-95. PubMed ID: 8021513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
    Vik DP; Fearon DT
    J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
    Ross GD; Lambris JD
    J Exp Med; 1982 Jan; 155(1):96-110. PubMed ID: 6915077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors.
    Edwards JE; Gaither TA; O'Shea JJ; Rotrosen D; Lawley TJ; Wright SA; Frank MM; Green I
    J Immunol; 1986 Dec; 137(11):3577-83. PubMed ID: 2946764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
    Fischer E; Appay MD; Cook J; Kazatchkine MD
    J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4).
    Frade R; Myones BL; Barel M; Krikorian L; Charriaut C; Ross GD
    Eur J Immunol; 1985 Dec; 15(12):1192-7. PubMed ID: 3878789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface markers of complement receptor lymphocytes.
    Ross GD; Winchester RJ; Rabellino EM; Hoffman T
    J Clin Invest; 1978 Nov; 62(5):1086-92. PubMed ID: 711854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-loaded but not free complement receptors for C3b/C4b and C3d co-cap with cross-linked B cell surface IgM and IgD.
    Tsokos GC; Thyphronitis G; Jack RM; Finkelman FD
    J Immunol; 1988 Aug; 141(4):1261-6. PubMed ID: 2969399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21).
    Esparza I; Becherer JD; Alsenz J; De la Hera A; Lao Z; Tsoukas CD; Lambris JD
    Eur J Immunol; 1991 Nov; 21(11):2829-38. PubMed ID: 1834472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane receptors of mouse leukocytes. I. Two types of complement receptors for different regions of C3.
    Rabellino EM; Ross GD; Polley MJ
    J Immunol; 1978 Mar; 120(3):879-85. PubMed ID: 632590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement receptors on Raji cells. The presence of a new type of C3 receptor.
    Okuda T; Tachibana T
    Immunology; 1980 Sep; 41(1):159-66. PubMed ID: 7429548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
    Gerdes J; Klatt U; Stein H
    Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells.
    Mold C; Nemerow GR; Bradt BM; Cooper NR
    J Immunol; 1988 Mar; 140(6):1923-9. PubMed ID: 2831273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL.
    Delibrias CC; Fischer E; Bismuth G; Kazatchkine MD
    J Immunol; 1992 Aug; 149(3):768-74. PubMed ID: 1386093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complement fragment C3d facilitates phagocytosis by monocytes.
    Gaither TA; Vargas I; Inada S; Frank MM
    Immunology; 1987 Nov; 62(3):405-11. PubMed ID: 3499379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells.
    Schmitt M; Mussel HH; Dierich MP
    J Immunol; 1981 May; 126(5):2042-7. PubMed ID: 7217681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.